Cell-Based Therapy for Canavan Disease Using Human iPSC-Derived NPCs and OPCs

25Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Canavan disease (CD) is a fatal leukodystrophy caused by mutation of the aspartoacylase (ASPA) gene, which leads to deficiency in ASPA activity, accumulation of the substrate N-acetyl-L-aspartate (NAA), demyelination, and spongy degeneration of the brain. There is neither a cure nor a standard treatment for this disease. In this study, human induced pluripotent stem cell (iPSC)-based cell therapy is developed for CD. A functional ASPA gene is introduced into patient iPSC-derived neural progenitor cells (iNPCs) or oligodendrocyte progenitor cells (iOPCs) via lentiviral transduction or TALEN-mediated genetic engineering to generate ASPA iNPC or ASPA iOPC. After stereotactic transplantation into a CD (Nur7) mouse model, the engrafted cells are able to rescue major pathological features of CD, including deficient ASPA activity, elevated NAA levels, extensive vacuolation, defective myelination, and motor function deficits, in a robust and sustainable manner. Moreover, the transplanted mice exhibit much prolonged survival. These genetically engineered patient iPSC-derived cellular products are promising cell therapies for CD. This study has the potential to bring effective cell therapies, for the first time, to Canavan disease children who have no treatment options. The approach established in this study can also benefit many other children who have deadly genetic diseases that have no cure.

References Powered by Scopus

Fast and accurate short read alignment with Burrows-Wheeler transform

33928Citations
N/AReaders
Get full text

The genome analysis toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

18695Citations
N/AReaders
Get full text

Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors

16556Citations
N/AReaders
Get full text

Cited by Powered by Scopus

ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response

163Citations
N/AReaders
Get full text

A Brief Overview of Global Trends in MSC-Based Cell Therapy

117Citations
N/AReaders
Get full text

Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases

33Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Feng, L., Chao, J., Tian, E., Li, L., Ye, P., Zhang, M., … Shi, Y. (2020). Cell-Based Therapy for Canavan Disease Using Human iPSC-Derived NPCs and OPCs. Advanced Science, 7(23). https://doi.org/10.1002/advs.202002155

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

58%

Researcher 3

25%

Professor / Associate Prof. 2

17%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 9

41%

Neuroscience 6

27%

Medicine and Dentistry 5

23%

Immunology and Microbiology 2

9%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free